Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Hamasy
Substitution Scanning Identifies a Novel, Catalytically Active Ibrutinib-Resistant BTK Cysteine 481 to Threonine (C481T) Variant
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-targeting Inhibitor
International Journal of Basic & Clinical Pharmacology
Lacticin 481 Synthetase as a General Serine/Threonine Kinase
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma
Community Oncology
Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma
British Journal of Haematology
Hematology
Synthetic Access to 3Substituted Pyroglutamic Acids From Tetramate Derivatives of Serine, Threonine, Allo-Threonine, and Cysteine
Structural Prediction of the Interaction of the Tumor Suppressor P27KIP1 With Cyclin a/Cdk2 Identifies a Novel Catalytically Relevant Determinant
BMC Bioinformatics
Biochemistry
Applied Mathematics
Computer Science Applications
Structural Biology
Molecular Biology
RNA Conformation in Catalytically Active Human Telomerase
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
Routes Towards Catalytically Active TiO2doped Porous Cellulose
RSC Advances
Chemistry
Chemical Engineering
Multiscale Modeling to Investigate Catalytically Active Enzymatic Aggregates for Cascade Bioreactions
Chemie-Ingenieur-Technik
Chemistry
Chemical Engineering
Manufacturing Engineering
Industrial